Skip Navigation


Rheumatology Advance Access originally published online on December 14, 2004
Rheumatology 2005 44(5):597-601; doi:10.1093/rheumatology/keh507
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
44/5/597    most recent
keh507v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Morgan, M. D.
Right arrow Articles by Savage, C. O. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morgan, M. D.
Right arrow Articles by Savage, C. O. S.
Related Collections
Right arrow Systemic Lupus Erythematosus and Autoimmunity
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2004. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org

REVIEW

Can neutrophils be manipulated in vivo?

Aims of Therapy/Series Editor: Lorraine Harper

M. D. Morgan, L. Harper, X. Lu, G. Nash, J. Williams and C. O. S. Savage

Renal Immunobiology, Division of Immunity and Infection, The School of Medicine, University of Birmingham, Birmingham, UK.

Correspondence to: C. O. S. Savage, Renal Immunobiology, Division of Immunity and Infection, The School of Medicine, University of Birmingham, Birmingham B15 2TT, UK. E-mail: c.o.s.savage@bham.ac.uk

The first 150 words of the full text of this article appear below.


   Introduction
 
Neutrophils are important effector cells of the innate immune system that are capable of responding rapidly to infectious organisms to which to the immune system may be naive. However, in certain circumstances their actions can be inappropriate or ineffective. A lack of effective neutrophil function increases the number or persistence of infections. This is well illustrated by inherited disorders that impair neutrophil effector function. In chronic granulomatous disease, deficient activity of NADPH oxidase (usually the membrane-bound gp91 subunit) results in the absence of a respiratory burst and the production of reactive oxygen species necessary for microbial killing, resulting in frequent infection. Defects in the leucocyte adhesion molecules (ß2 integrins or selectin molecules) necessary for neutrophil interaction with endothelium lead to poor recruitment to sites of infection and hence an inability to effectively fight infection [1].

In some patients the opposite situation occurs, where inappropriate and prolonged neutrophil activation . . . [Full Text of this Article]


   Neutrophil recruitment
 

   Selectins as targets for manipulating neutrophil recruitment
 

   Inhibition via neutrophil integrins or their endothelial ligands
 

   The chemokine receptors CXCR1 and CXCR2 as targets for neutrophil manipulation
 

   Down-regulating neutrophil activation at the level of receptor-mediated events or intracellular signalling pathways
 
Receptor-mediated events
Intracellular signalling pathways

   Targeting cytotoxic products of neutrophil activation
 

   Manipulating neutrophil life span and/or promoting non-phlogistic removal
 

   Summary
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?